Vimarsana
Biggest News Aggregation in the World

Call There News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Call There. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Call There Today - Breaking & Trending Today

Can't get that printer to work? It's not you. It's that sodding cablin.... oh beautiful job with that cabling, boss - Vimarsana News

Can't get that printer to work? It's not you. It's that sodding cablin.... oh beautiful job with that cabling, boss

Goodbye, Mr Chips Share Copy On Call There are few things worse than when someone nicks your chips, be they of the potato or silicon variety as our latest delve into the annals of On Call reveals. "Ben", as the Regomiser has dubbed today's contributor, was tasked with supporting a network consisting of a pair of decade old HP1000 minicomputers. The devices ran the Real Time Executive (RTE) operating system (RTE6, according to Ben) and the software used by his company was written in Fortran. The application itself was to analyse oil wells and a Versatec plotter was used to spit out a c...

For blinkenlights sake.... RTFM! Yes. Read The Front of the Machine - Vimarsana News

For blinkenlights sake.... RTFM! Yes. Read The Front of the Machine

Before smartphones and LCD displays there were... green lights and red lights Richard Speed Fri 9 Apr 2021 // 07:05 UTC Share Copy On Call There was a time before phones went wireless (and before Apple made sure we all carried a spare charge cable.) Take a trip back to those halcyon days with another entry in the pages of On Call. Our story, told by a Register reader we'll call "Andrew" (not his name), takes us back 40 years to when he was an IT manager of an oil survey company. It was an exciting time. He got to travel the world installing computer gear in the form o...

Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure - Vimarsana News

Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure

Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure NEW YORK, Dec. 14, 2020 — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced top-line results from the landmark DREAM-HF Phase 3 randomized controlled trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR ®) in 537 patients with advanced chronic heart failure 1. Over a mean 30 months o...